This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goetz, R.
Right arrow Articles by Mohammadi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goetz, R.
Right arrow Articles by Mohammadi, M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, May 2007, p. 3417-3428, Vol. 27, No. 9
0270-7306/07/$08.00+0     doi:10.1128/MCB.02249-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Molecular Insights into the Klotho-Dependent, Endocrine Mode of Action of Fibroblast Growth Factor 19 Subfamily Members{triangledown}

Regina Goetz,1 Andrew Beenken,1 Omar A. Ibrahimi,1 Juliya Kalinina,1 Shaun K. Olsen,1 Anna V. Eliseenkova,1 ChongFeng Xu,1,7 Thomas A. Neubert,1 Fuming Zhang,2,7 Robert J. Linhardt,2 Xijie Yu,3 Kenneth E. White,3 Takeshi Inagaki,4 Steven A. Kliewer,4 Masaya Yamamoto,5 Hiroshi Kurosu,5 Yasushi Ogawa,5 Makoto Kuro-o,5 Beate Lanske,6 Mohammed S. Razzaque,6 and Moosa Mohammadi1*

Department of Pharmacology,1 Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, New York 10016,7 Department of Chemistry, Biology, and Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, New York 12180,2 Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana 46202,3 Department of Molecular Biology,4 Department of Pathology, The University of Texas Southwestern Medical Center at Dallas, 6000 Harry Hines Blvd., Dallas, Texas 75390,5 Department of Oral and Developmental Biology, Harvard School of Dental Medicine, Boston, Massachusetts 021156

Received 30 November 2006/ Accepted 15 February 2007

Unique among fibroblast growth factors (FGFs), FGF19, -21, and -23 act in an endocrine fashion to regulate energy, bile acid, glucose, lipid, phosphate, and vitamin D homeostasis. These FGFs require the presence of Klotho/ßKlotho in their target tissues. Here, we present the crystal structures of FGF19 alone and FGF23 in complex with sucrose octasulfate, a disaccharide chemically related to heparin. The conformation of the heparin-binding region between ß strands 10 and 12 in FGF19 and FGF23 diverges completely from the common conformation adopted by paracrine-acting FGFs. A cleft between this region and the ß1-ß2 loop, the other heparin-binding region, precludes direct interaction between heparin/heparan sulfate and backbone atoms of FGF19/23. This reduces the heparin-binding affinity of these ligands and confers endocrine function. Klotho/ßKlotho have evolved as a compensatory mechanism for the poor ability of heparin/heparan sulfate to promote binding of FGF19, -21, and -23 to their cognate receptors.

* Corresponding author. Mailing address: Department of Pharmacology, New York University School of Medicine, New York, NY 10016. Phone: (212) 263-2907. Fax: (212) 263-7133. E-mail: mohammad{at}saturn.med.nyu.edu

{triangledown} Published ahead of print on 5 March 2007.

Molecular and Cellular Biology, May 2007, p. 3417-3428, Vol. 27, No. 9
0270-7306/07/$08.00+0     doi:10.1128/MCB.02249-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Bergwitz, C., Banerjee, S., Abu-Zahra, H., Kaji, H., Miyauchi, A., Sugimoto, T., Juppner, H. (2009). Defective O-Glycosylation due to a Novel Homozygous S129P Mutation Is Associated with Lack of Fibroblast Growth Factor 23 Secretion and Tumoral Calcinosis. J. Clin. Endocrinol. Metab. 94: 4267-4274 [Abstract] [Full Text]  
  • Nakatani, T., Ohnishi, M., Razzaque, M. S. (2009). Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. FASEB J. 23: 3702-3711 [Abstract] [Full Text]  
  • Xu, J., Stanislaus, S., Chinookoswong, N., Lau, Y. Y., Hager, T., Patel, J., Ge, H., Weiszmann, J., Lu, S.-C., Graham, M., Busby, J., Hecht, R., Li, Y.-S., Li, Y., Lindberg, R., Veniant, M. M. (2009). Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects. Am. J. Physiol. Endocrinol. Metab. 297: E1105-E1114 [Abstract] [Full Text]  
  • Makarenkova, H. P., Hoffman, M. P., Beenken, A., Eliseenkova, A. V., Meech, R., Tsau, C., Patel, V. N., Lang, R. A., Mohammadi, M. (2009). Differential Interactions of FGFs with Heparan Sulfate Control Gradient Formation and Branching Morphogenesis. Sci Signal 2: ra55-ra55 [Abstract] [Full Text]  
  • Kalinina, J., Byron, S. A., Makarenkova, H. P., Olsen, S. K., Eliseenkova, A. V., Larochelle, W. J., Dhanabal, M., Blais, S., Ornitz, D. M., Day, L. A., Neubert, T. A., Pollock, P. M., Mohammadi, M. (2009). Homodimerization Controls the Fibroblast Growth Factor 9 Subfamily's Receptor Binding and Heparan Sulfate-Dependent Diffusion in the Extracellular Matrix. Mol. Cell. Biol. 29: 4663-4678 [Abstract] [Full Text]  
  • Wu, X., Ge, H., Lemon, B., Weiszmann, J., Gupte, J., Hawkins, N., Li, X., Tang, J., Lindberg, R., Li, Y. (2009). Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice. Proc. Natl. Acad. Sci. USA 106: 14379-14384 [Abstract] [Full Text]  
  • Chavez, A. O., Molina-Carrion, M., Abdul-Ghani, M. A., Folli, F., DeFronzo, R. A., Tripathy, D. (2009). Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance. Diabetes Care 32: 1542-1546 [Abstract] [Full Text]  
  • Gattineni, J., Bates, C., Twombley, K., Dwarakanath, V., Robinson, M. L., Goetz, R., Mohammadi, M., Baum, M. (2009). FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am. J. Physiol. Renal Physiol. 297: F282-F291 [Abstract] [Full Text]  
  • Potthoff, M. J., Inagaki, T., Satapati, S., Ding, X., He, T., Goetz, R., Mohammadi, M., Finck, B. N., Mangelsdorf, D. J., Kliewer, S. A., Burgess, S. C. (2009). FGF21 induces PGC-1{alpha} and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc. Natl. Acad. Sci. USA 106: 10853-10858 [Abstract] [Full Text]  
  • Kuro-o, M. (2009). Klotho in chronic kidney disease--What's new?. Nephrol Dial Transplant 24: 1705-1708 [Full Text]  
  • Farrow, E. G., Davis, S. I., Summers, L. J., White, K. E. (2009). Initial FGF23-Mediated Signaling Occurs in the Distal Convoluted Tubule. J. Am. Soc. Nephrol. 20: 955-960 [Abstract] [Full Text]  
  • Shin, D.-J., Osborne, T. F. (2009). FGF15/FGFR4 Integrates Growth Factor Signaling with Hepatic Bile Acid Metabolism and Insulin Action. J. Biol. Chem. 284: 11110-11120 [Abstract] [Full Text]  
  • Razzaque, M. S. (2009). FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?. Am. J. Physiol. Renal Physiol. 296: F470-F476 [Abstract] [Full Text]  
  • Nakatani, T., Sarraj, B., Ohnishi, M., Densmore, M. J., Taguchi, T., Goetz, R., Mohammadi, M., Lanske, B., Razzaque, M. S. (2009). In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis. FASEB J. 23: 433-441 [Abstract] [Full Text]  
  • Razzaque, M. S. (2009). Does FGF23 toxicity influence the outcome of chronic kidney disease?. Nephrol Dial Transplant 24: 4-7 [Full Text]  
  • Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., Chen, J.-L., Young Jung, D., Zhang, Z., Ko, H.-J., Kim, J. K., Veniant, M. M. (2009). Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice. Diabetes 58: 250-259 [Abstract] [Full Text]  
  • Wu, X., Lemon, B., Li, X., Gupte, J., Weiszmann, J., Stevens, J., Hawkins, N., Shen, W., Lindberg, R., Chen, J.-L., Tian, H., Li, Y. (2008). C-terminal Tail of FGF19 Determines Its Specificity toward Klotho Co-receptors. J. Biol. Chem. 283: 33304-33309 [Abstract] [Full Text]  
  • Sinha, J., Chen, F., Miloh, T., Burns, R. C., Yu, Z., Shneider, B. L. (2008). {beta}-Klotho and FGF-15/19 inhibit the apical sodium-dependent bile acid transporter in enterocytes and cholangiocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G996-G1003 [Abstract] [Full Text]  
  • Garringer, H. J., Malekpour, M., Esteghamat, F., Mortazavi, S. M. J., Davis, S. I., Farrow, E. G., Yu, X., Arking, D. E., Dietz, H. C., White, K. E. (2008). Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis. Am. J. Physiol. Endocrinol. Metab. 295: E929-E937 [Abstract] [Full Text]  
  • Razzaque, M. S. (2008). Klotho and Na+,K+-ATPase activity: solving the calcium metabolism dilemma?. Nephrol Dial Transplant 23: 459-461 [Full Text]  
  • Wu, X., Ge, H., Gupte, J., Weiszmann, J., Shimamoto, G., Stevens, J., Hawkins, N., Lemon, B., Shen, W., Xu, J., Veniant, M. M., Li, Y.-S., Lindberg, R., Chen, J.-L., Tian, H., Li, Y. (2007). Co-receptor Requirements for Fibroblast Growth Factor-19 Signaling. J. Biol. Chem. 282: 29069-29072 [Abstract] [Full Text]  
  • Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., Kuro-o, M. (2007). Tissue-specific Expression of betaKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21. J. Biol. Chem. 282: 26687-26695 [Abstract] [Full Text]  
  • Lin, B. C., Wang, M., Blackmore, C., Desnoyers, L. R. (2007). Liver-specific Activities of FGF19 Require Klotho beta. J. Biol. Chem. 282: 27277-27284 [Abstract] [Full Text]  
  • Razzaque, M. S, Lanske, B. (2007). The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis. J Endocrinol 194: 1-10 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»